Q2 2021

Filed Aug 11, 2021 · 10-Q · 42 days after period end · 0001140361-21-027937

Q2 2021 · 10-Q

Revenue

$0.00

−100.0% vs Q2 2020

Net Income

-$617.00K

N/M vs Q2 2020

EPS Diluted

-$0.08

N/M vs Q2 2020

Operating Income-$249,000N/M

Operating Cash Flow

Same quarter

Metric	Q2 2021	Q2 2020	Q2 2019	Q2 2018
Revenue	$0.00	$596.00K	$825.00K	$1.12M
Net Income	-$617.00K	$45.00K	-$59.00K	$77.00K
EPS Diluted	-$0.08	$0.01	-$0.01	$0.01

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Elite Health Systems Inc. · CIK 1089815 · Engraved from SEC EDGAR